Who are Aurase Wound gel's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): MEBO Wound Ointment, ON101 Cream, Chitosan-Hyaluronate Gel Mixture, Fitostimoline ® hydrogel group, KeraStat® Gel application, Hyaluronic Acid mouthwash.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/aurase-wound-gel.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Aurase Wound gel — Competitive Intelligence Brief

Aurase Wound gel (Aurase Wound gel) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Wound healing agent. Area: Wound healing.

phase 2 Wound healing agent Wound healing Small molecule Live · refreshed every 30 min

Target snapshot

Aurase Wound gel (Aurase Wound gel) — SolasCure Limited. Aurase Wound gel promotes wound healing through the stimulation of cellular processes.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Aurase Wound gel TARGET	Aurase Wound gel	SolasCure Limited	phase 2	Wound healing agent
MEBO Wound Ointment	MEBO Wound Ointment	Skingenix, Inc.	marketed	Topical wound healing agent
ON101 Cream	ON101 Cream	Oneness Biotech Co., Ltd.	marketed	Topical wound healing agent	Fibroblast growth factor receptor (FGFR)
Chitosan-Hyaluronate Gel Mixture	Chitosan-Hyaluronate Gel Mixture	Ain Shams University	marketed	Biomaterial/Wound healing agent
Fitostimoline ® hydrogel group	Fitostimoline ® hydrogel group	Federico II University	marketed	Wound healing agent
KeraStat® Gel application	KeraStat® Gel application	The Metis Foundation	marketed	Topical wound healing agent
Hyaluronic Acid mouthwash	Hyaluronic Acid mouthwash	University of Jordan	marketed	Topical biopolymer / wound healing agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Wound healing agent class)

Centre Francois Baclesse · 1 drug in this class
Daryoush Hamidi Alamdari, PhD · 1 drug in this class
Federico II University · 1 drug in this class
SolasCure Limited · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Aurase Wound gel — Competitive Intelligence Brief. https://druglandscape.com/ci/aurase-wound-gel. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab